Ongoing trials in low-grade lymphoma
There are many therapies available for the management of low-grade lymphoma. With follicular lymphoma, for example, combination of chemotherapy and rituximab (immuno-chemo - therapy) and consecutive maintenance therapy for 2 years is the current standard of care. To date, the most widely used regime...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-10-01
|
Series: | Hematology Reports |
Subjects: | |
Online Access: | http://www.pagepress.org/journals/index.php/hr/article/view/3872 |